Myocardial viability assessment using nuclear imaging

Area of Science:

• Cardiology
• Nuclear Medicine
• Medical Imaging

Background:

• Myocardial viability assessment is critical for managing coronary artery disease and left ventricular dysfunction.
• Nuclear imaging techniques, particularly PET and SPECT, have historically been central to viability assessment.

Purpose of the Study:

• To review the role of nuclear imaging in myocardial viability assessment.
• To compare PET and SPECT techniques and discuss emerging competitors.
• To highlight the need for continued improvement in nuclear imaging diagnostic performance.

Main Methods:

• Review of current literature on myocardial viability assessment using nuclear imaging.
• Comparison of Positron Emission Tomography (PET) with 18F-fluorodeoxyglucose and Single-Photon Emission Computed Tomography (SPECT).
• Discussion of complementary roles of other imaging modalities like dobutamine echocardiography.

Main Results:

• 18F-fluorodeoxyglucose PET is considered the metabolic gold standard for tissue viability.
• SPECT is more widely accepted clinically due to availability and lower cost, with advancements like gated-SPECT improving accuracy.
• Emerging techniques like dobutamine echocardiography present alternatives and potential complementary uses.

Conclusions:

• Nuclear imaging remains a cornerstone for myocardial viability assessment in patients with coronary artery disease.
• While PET offers metabolic gold standard data, SPECT provides a cost-effective and widely accessible alternative.
• Integration with other imaging modalities and continued technological advancements are key to enhancing diagnostic accuracy.